New therapies selected with potential to reduce COVID-19 death risk: WHO

Published: Updated:
Read Mode
100% Font Size

The World Health Organization on Wednesday said a clinical trial in 52 countries will study three anti-inflammatory drugs as potential treatments for COVID-19 patients.

For the latest headlines, follow our Google News channel online or via the app.

“These therapies - artesunate, imatinib and infliximab – were selected by an independent expert panel for their potential in reducing the risk of death in hospitalized COVID-19 patients,” it said in a statement.

Artesunate is already used for severe malaria, imatinib for certain cancers, and infliximab for diseases of the immune system such as Crohn’s Disease and rheumatoid arthritis.

Read more:

COVID-19 anti-vaxxers can derail fight against pandemic: UAE health experts

UAE records lowest daily number of new COVID-19 cases in three months

Coronavirus: The top conspiracy theories surrounding COVID-19

Top Content Trending